Skip to content
Research Article Open access CC BY 4.0

Nonalcoholic Fatty Liver Disease (NAFLD) in Saudi Patients with T2DM in Jazan Region: Prevalence and Associated Factors

Erwa Elmakki, Hussein Aqeely, Ibrahim Bani, Husam Omer, Yahya Solan, Asim Taher, Talal Hadi, Musa Mohammed, Saif Elden Abdalla, Mohammed S. Mahfouz

Journal of Advances in Medicine and Medical Research · pp. 872–879 · Published 10 Oct 2014

10.9734/BJMMR/2015/13077

Abstract

Backgrounds: Non-alcoholic fatty liver disease (NAFLD) has become one of the major health problems world widely, especially among communities with sedentary lifestyle. The main objectives of this study were to know the prevalence of NAFLD among Saudi patients with T2DM in Jazan region and to determine the most important associated factors. Materials and Methods: A cross sectional study targeted 230 type 2 diabetic patients, who attended Diabetic Center at Jazan General Hospital. All participants were screened for NAFLD using abdominal ultrasonography in addition to clinical and laboratory workup. Descriptive statistics, Chi square/Fisher exact test and logistic regression were utilized for data analysis. Results: The prevalence of fatty liver in the present study was 47.8% (95% CI 41.1–54.6), with no significant difference between males 49.1% (95% CI 40.0–58.3) and females 46.3% (95% CI 36.6-56.3). The prevalence of NAFLD was found to be 52.9% among patients who their ages range between 40-59 years. Factors associated with NAFLD were found to be age, uric acid, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (p-value<0.05 for all). Conclusion: NAFLD is tremendously common among people with type 2 diabetes in Jazan region and the major associated factors were age, obesity, uric acid and elevated liver enzymes. There was no positive correlation between the presence of fatty liver and duration of DM or the degree of glycemic control.

Non-alcoholic fatty liver disease T2DM.

Cited by 31

Management of non-alcoholic fatty liver disease in patients with sarcopenia

Ching-Sheng Hsu, Jia-Horng Kao · Expert Opinion on Pharmacotherapy · 2021

An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia

Ching-Sheng Hsu, Jia-Horng Kao · Expert Review of Gastroenterology & Hepatology · 2017

Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia

Abdullah A. Alsabaani, Ahmed A. Mahfouz, Nabil J. Awadalla · International Journal of Environmental Research and Public Health · 2018

Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes

Assim A. Alfadda, Suphia M. Sherbeeni, Adel N. Alqutub · Saudi Journal of Gastroenterology · 2022

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030

Khalid Alswat, Abdulrahman A Aljumah, Faisal M Sanai · Saudi Journal of Gastroenterology · 2018

Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease

Hua Zhu, Zhenjiong Wang, Yulong Wu · International Journal of Biological Macromolecules · 2019

Showing 15 of 31 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

13

Page views

0

PDF downloads

1

Outbound clicks

31

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.